Clinical Trial Details
EORTC-62006
Back to Clinical Trials Database
Exatecan as second line treatment in advanced adult soft tissue sarcoma: A phase II study of the EORTC Soft Tissue and Bone sarcoma Group. (Study only open for patients with Leiomyosarcoma)
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 15-May-2002 Date Step1 close: 01-Dec-2004 |
| Data management at EORTC | Yes |
| Design |
Phase 2 Randomized open label |
| Targeted Sample size | EORTC Groups: 50 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00041236 |
| NCT number | NCT00041236 |
